What is Johnson & Johnson's trauma — percent change (as a percent)?

Johnson & Johnson (JNJ) reported trauma — percent change (as a percent) of 8.0% in Q1 2026.

How has Johnson & Johnson's trauma — percent change (as a percent) changed year-over-year?

Johnson & Johnson's trauma — percent change (as a percent) increased by 788.9% year-over-year, from 0.9% to 8.0%.

What is the long-term trend for Johnson & Johnson's trauma — percent change (as a percent)?

Over 3 years (2022 to 2025), Johnson & Johnson's trauma — percent change (as a percent) has grown at a 191.1% compound annual growth rate (CAGR), from -0.3% to 7.4%.

What does trauma — percent change (as a percent) mean?

The percentage growth or decline in revenue from trauma-related medical products compared to the previous period.

Products & Services · Percent Change (as a percent)

TRAUMA — Percent Change (as a percent)

Johnson & Johnson TRAUMA — Percent Change (as a percent) increased by 627.3% to 8.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 788.9%, from 0.9% to 8.0%. Over 3 years (FY 2022 to FY 2025), TRAUMA — Percent Change (as a percent) shows an upward trend with a 191.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ1 2018

Last reportedQ1 2026Apr 22, 2026

How to read this metric

A positive percentage indicates organic or inorganic growth in the trauma segment, whereas a negative percentage suggests a contraction in sales volume or pricing power within the trauma market.

Detailed definition

This metric measures the period-over-period growth rate of revenue generated from the trauma product line. It isolates t...

Peer comparison

Comparable to the organic or reported revenue growth rates of specific medical device product lines at diversified healthcare competitors.

Metric ID: jnj_segment_trauma_percent_change_as_a_percent

Historical Data

19 periods

	Q2 '21	Q3 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	28.4%	4.2%	2.1%	-1.9%	0.2%	-0.7%	1.2%	6.1%	3.5%	0.3%	1%	2.8%	2.6%	0.2%	0.9%	1.2%	4.2%	1.1%	8%
QoQ Change	—	-85.2%	-50.0%	-190.5%	+110.5%	-450.0%	+271.4%	+408.3%	-42.6%	-91.4%	+233.3%	+180.0%	-7.1%	-92.3%	+350.0%	+33.3%	+250.0%	-73.8%	+627.3%
YoY Change	—	—	—	-106.7%	-95.2%	—	-42.9%	+421.1%	>999%	+142.9%	-16.7%	-54.1%	-25.7%	-33.3%	-10.0%	-57.1%	+61.5%	+450.0%	+788.9%

Range-1.9% – 28.4%

CAGR-24.5%

Avg YoY Growth+204.8%

Median YoY Growth-16.7%

Similar Metrics at Other Companies

Natera, Inc.NTRA View metric

Kimberly-ClarkKMB View metric

Gilead SciencesGILD View metric

ROP

Roper Technologies, Inc.ROP View metric

ROP

Roper Technologies, Inc.ROP View metric

Kimberly-ClarkKMB View metric

Frequently Asked Questions

What is Johnson & Johnson's trauma — percent change (as a percent)?: Johnson & Johnson (JNJ) reported trauma — percent change (as a percent) of 8.0% in Q1 2026.
How has Johnson & Johnson's trauma — percent change (as a percent) changed year-over-year?: Johnson & Johnson's trauma — percent change (as a percent) increased by 788.9% year-over-year, from 0.9% to 8.0%.
What is the long-term trend for Johnson & Johnson's trauma — percent change (as a percent)?: Over 3 years (2022 to 2025), Johnson & Johnson's trauma — percent change (as a percent) has grown at a 191.1% compound annual growth rate (CAGR), from -0.3% to 7.4%.
What does trauma — percent change (as a percent) mean?: The percentage growth or decline in revenue from trauma-related medical products compared to the previous period.